Ozempic provokes another scandal in Luxembourg by launching a wave of inspections
Haberdoedas, Unsplash
The Ministry of Health and CNS carry out retrospective monitoring of prescription data, as they do not have direct access to prescriptions. If incorrect prescriptions are suspected, a further investigation is carried out with the participation of the medical inspectorate of social care.
If violations are found, the materials are referred to the CNS Supervisory Commission, which decides on further measures.
A case involving Ozempic, a drug often used to treat diabetes, has recently come to the attention of the commission. To date, CNS has referred one such case to the commission. The case is being reviewed with the involvement of the College of Medicine, which has also been informed.
Although the Ministry of Health does not randomly check prescriptions, the CNS monitoring system allows for the identification of suspicious cases. The approach is aimed at identifying violations that have already occurred, thus creating an incentive for doctors to comply with prescribing rules.
